Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 11 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas				Phase III				GPOH-HIT-GBM-D EU-205100, NCT00278278
	Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma				Phase II, Phase I				SJCRH-SJHG04 GENENTECH-OSI3160s, NCT00124657
	A Phase I/II Study of the Photon Radiosurgery System				Phase II, Phase I				CNS 0201 NCT00179907
	A Multi-Center Phase I Study of AP23573 in Pediatric Patients With Advanced Solid Tumors				Phase II, Phase I				SUN08-01 NCT00704054
	Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors				Phase II, Phase I				CHNMC-07053 07053, CA180 121, NCT00788125
	Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma				Phase II				PBTC-022 NCT00381797
	Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-Cis-Retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors				Phase II				NYU 05-40 H12853 PBMTC ONC-032P, NCT00528437
	AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors				Phase I				PBTC-020 NCT00326664
	MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer				Phase I				PBTC-024 PBTC-024, NCT00572182
	Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas				No phase specified				SIOP-LGG-2004 EU-20555, NCT00276640


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute